ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/16 | 1,352 | 1,364 | 1,344 | 1,351 | -27 | -2% | 382,400 |
| 2022/12/15 | 1,382 | 1,396 | 1,378 | 1,378 | -6 | -0.4% | 197,300 |
| 2022/12/14 | 1,402 | 1,405 | 1,376 | 1,384 | +1 | +0.1% | 285,500 |
| 2022/12/13 | 1,405 | 1,419 | 1,380 | 1,383 | -8 | -0.6% | 243,100 |
| 2022/12/12 | 1,380 | 1,408 | 1,370 | 1,391 | -9 | -0.6% | 340,000 |
| 2022/12/09 | 1,392 | 1,404 | 1,380 | 1,400 | +16 | +1.2% | 303,200 |
| 2022/12/08 | 1,407 | 1,416 | 1,368 | 1,384 | -36 | -2.5% | 547,800 |
| 2022/12/07 | 1,404 | 1,425 | 1,391 | 1,420 | +2 | +0.1% | 295,300 |
| 2022/12/06 | 1,430 | 1,462 | 1,417 | 1,418 | -20 | -1.4% | 353,300 |
| 2022/12/05 | 1,442 | 1,447 | 1,401 | 1,438 | -9 | -0.6% | 302,100 |
| 2022/12/02 | 1,455 | 1,474 | 1,438 | 1,447 | +10 | +0.7% | 512,900 |
| 2022/12/01 | 1,432 | 1,446 | 1,418 | 1,437 | +25 | +1.8% | 353,700 |
| 2022/11/30 | 1,427 | 1,444 | 1,406 | 1,412 | -2 | -0.1% | 475,800 |
| 2022/11/29 | 1,395 | 1,424 | 1,378 | 1,414 | +9 | +0.6% | 386,800 |
| 2022/11/28 | 1,407 | 1,430 | 1,391 | 1,405 | -15 | -1.1% | 538,900 |
| 2022/11/25 | 1,451 | 1,457 | 1,414 | 1,420 | -45 | -3.1% | 515,100 |
| 2022/11/24 | 1,495 | 1,512 | 1,456 | 1,465 | -35 | -2.3% | 527,200 |
| 2022/11/22 | 1,478 | 1,503 | 1,462 | 1,500 | ±0 | ±0% | 440,100 |
| 2022/11/21 | 1,507 | 1,527 | 1,471 | 1,500 | +16 | +1.1% | 688,200 |
| 2022/11/18 | 1,445 | 1,503 | 1,433 | 1,484 | +39 | +2.7% | 706,800 |
| 2022/11/17 | 1,511 | 1,528 | 1,445 | 1,445 | -102 | -6.6% | 1,104,000 |
| 2022/11/16 | 1,610 | 1,650 | 1,543 | 1,547 | -25 | -1.6% | 1,176,600 |
| 2022/11/15 | 1,575 | 1,669 | 1,522 | 1,572 | +92 | +6.2% | 2,050,300 |
| 2022/11/14 | 1,452 | 1,493 | 1,444 | 1,480 | +29 | +2% | 497,900 |
| 2022/11/11 | 1,456 | 1,472 | 1,437 | 1,451 | +33 | +2.3% | 520,400 |
| 2022/11/10 | 1,388 | 1,427 | 1,377 | 1,418 | +19 | +1.4% | 270,800 |
| 2022/11/09 | 1,434 | 1,448 | 1,398 | 1,399 | -34 | -2.4% | 277,400 |
| 2022/11/08 | 1,420 | 1,453 | 1,418 | 1,433 | +25 | +1.8% | 321,200 |
| 2022/11/07 | 1,384 | 1,413 | 1,372 | 1,408 | +24 | +1.7% | 314,100 |
| 2022/11/04 | 1,415 | 1,427 | 1,375 | 1,384 | -56 | -3.9% | 475,700 |
| 2022/11/02 | 1,417 | 1,453 | 1,412 | 1,440 | +15 | +1.1% | 386,800 |
| 2022/11/01 | 1,415 | 1,431 | 1,403 | 1,425 | +9 | +0.6% | 292,800 |
| 2022/10/31 | 1,450 | 1,454 | 1,408 | 1,416 | -18 | -1.3% | 474,700 |
| 2022/10/28 | 1,448 | 1,463 | 1,428 | 1,434 | -19 | -1.3% | 503,500 |
| 2022/10/27 | 1,412 | 1,467 | 1,410 | 1,453 | +31 | +2.2% | 534,200 |
| 2022/10/26 | 1,406 | 1,494 | 1,405 | 1,422 | +14 | +1% | 1,206,700 |
| 2022/10/25 | 1,354 | 1,411 | 1,351 | 1,408 | +53 | +3.9% | 723,800 |
| 2022/10/24 | 1,355 | 1,365 | 1,315 | 1,355 | -21 | -1.5% | 854,600 |
| 2022/10/21 | 1,332 | 1,384 | 1,330 | 1,376 | +38 | +2.8% | 744,700 |
| 2022/10/20 | 1,304 | 1,338 | 1,291 | 1,338 | +11 | +0.8% | 647,300 |
| 2022/10/19 | 1,326 | 1,339 | 1,293 | 1,327 | +2 | +0.2% | 627,100 |
| 2022/10/18 | 1,285 | 1,328 | 1,280 | 1,325 | +55 | +4.3% | 684,300 |
| 2022/10/17 | 1,238 | 1,285 | 1,229 | 1,270 | +11 | +0.9% | 556,000 |
| 2022/10/14 | 1,230 | 1,267 | 1,221 | 1,259 | +46 | +3.8% | 474,100 |
| 2022/10/13 | 1,228 | 1,244 | 1,203 | 1,213 | -4 | -0.3% | 314,900 |
| 2022/10/12 | 1,228 | 1,241 | 1,210 | 1,217 | -18 | -1.5% | 322,900 |
| 2022/10/11 | 1,253 | 1,265 | 1,227 | 1,235 | ±0 | ±0% | 529,700 |
| 2022/10/07 | 1,247 | 1,260 | 1,230 | 1,235 | -33 | -2.6% | 380,200 |
| 2022/10/06 | 1,239 | 1,269 | 1,236 | 1,268 | +23 | +1.8% | 446,000 |
| 2022/10/05 | 1,260 | 1,291 | 1,235 | 1,245 | -13 | -1% | 441,500 |
501～
550
件表示中 / 3611件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 361,000円 | +52.1% | +23.3% | - | - | - |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 450,000円 | +22.8% | +113.0% | - | - | - |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 417,000円 | +14.5% | -2.3% | - | - | - |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 333,000円 | +15.0% | -7.3% | - | - | - |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 469,500円 | +12.0% | +28.1% | - | - | - |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
